When a clinical trial has no drug to ship, what becomes supply? Non-pharmacological trials still require sourcing, tracking, qualification, and control.
- AI In Clinical Supply: From Forecasting To Execution Decisions
- Accountability Gaps Can Break Clinical Supply Contracts
- When Clinical Supply Becomes A Clinical Decision
- How To Build Clinical Supply Into Drug Development From The Start
- When Communication Fails, Clinical Supply Risk Grows
- When IRT Configuration Decisions Disrupt Clinical Supply
- Fixing The Data Problem Before AI Can Help Clinical Trial Supply
- The Shipment Arrived. The Inventory Didn't: Understanding The Hidden Data Dependencies Behind Depot-To-Site Deliveries
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Ensure Seamless, Efficient Delivery Of Clinical Trial Materials Worldwide
Drug discovery companies, CROs, and CDMOs are under pressure to find supply management solutions that ensure delivery of clinical trial materials while navigating complex study designs and the regulatory landscape.
-
Revolutionizing Trial Supply Management With The Power Of Free Picking
Discover the power of SmartSignals RTSM’s new free picking feature, designed to revolutionize trial supply management by optimizing efficiency and reducing costs.
-
How Intelligent IRT Is Redefining Clinical Supply Chains
Traditional clinical supply chains can't keep up. Learn how smart IRT platforms use real-time data to prevent shortages, cut waste, and keep trials running smoothly.
-
Delivering Lifesaving Intravenous Therapy Across The USA Within 24 Hours
The goal was to successfully deliver time-critical intravenous therapy, Legalon, from a GMP Philadelphia depot to sites across the USA to treat patients suffering from amatoxin poisoning.
-
Functional Testing Summary Of Daikyo Crystal Zenith Nested Vials
The Daikyo Crystal Zenith nested vials meet the exterior dimensions of the glass standard ISO 8362-1. The vials maintain CCI for up to 6 months and can withstand ultra-cold temperatures and drop conditions.
-
Emerging Biopharm Rapidly Sets Up Phase 1 Oncology Trial
Uncover how an emerging biopharmaceutical company was able to expedite the initiation of a Phase 1 oncology trial for a novel treatment targeting relapsed/refractory multiple myeloma.
-
Optimizing IRT For Clinical Supply Management
Experts speak on supply capabilities within interactive response technology (IRT) – how flexibility is important to functionality and who to involve and which questions to ask in optimizing IRT for clinical supply.
-
Building Better Resilience Into Your Clinical Supply Strategy
Reliable clinical supply requires proper vendor selection, cross-functional communication, and safety nets built to accommodate an ever-changing geopolitical and global pharmaceutical landscape. To avoid supply disruptions for clinical drugs, sponsors must give clinical supply its proper weight in initial protocol development and trial design.
-
Managing Clinical Trial Supply Challenges In Complex Studies
Complex studies require flexible supply strategies that can adjust to shifting timelines, varied modalities, and global site needs. Adaptive, scalable planning helps lower risk.
-
A Guide To RTSM For Clinical Trials
Looking ahead, the evolution of RTSM in clinical trials points towards cloud-based solutions, heightened emphasis on patient safety, and greater collaboration among stakeholders. Learn how you can prepare.
- Can Your Operating Model Grow? Preparing Clinical Supply For What Comes Next
- The Biggest Early-Stage Clinical Supply Mistake? Building Too Much, Too Soon.
- How Clinical Supply Is Shaping The Next Generation Of Cell And Gene Therapies
- First Advisors In: Meet Clinical Supply Leader's Inaugural Board Members
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.